FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000545788> ?p ?o ?g. }

• W2000545788 endingPage "420" @default.
• W2000545788 startingPage "415" @default.
• W2000545788 abstract "Current treatment modalities can cure up to 70-80 % of patients with classical Hodgkin lymphoma. Approximately, 20-30 % of patients require further treatment options. Brentuximab vedotin has been approved for the treatment of relapsed and refractory Hodgkin lymphoma. In the present study, we report the experience with brentuximab vedotin as single agent in 58 patients with relapsed or refractory Hodgkin lymphoma. The objective response rate was 63.5 % with 13 complete responders (26.5 %) among 49 patients evaluated at the early phase of treatment (2-5 cycles). Upon treatment prolongation (≥6 cycles), 37 patients achieved a final objective response rate of 32.4 % with 21.6 % of complete and 10.8 % of partial response. Overall survival at 12 months was 70.6 %, and progression-free survival at 12 months was 32.8 %. Median overall survival could not be reached and median progression-free survival was 7 months. While the median duration of response was 9 months in the whole cohort, it was 11.5 months in the complete responders. Complete response rates in patients treated with >3 chemotherapy regimens before brentuximab vedotin were significantly lower (p = 0.016). Fourteen patients were subsequently transplanted. In conclusion, brentuximab vedotin provided a bridge to transplantation in approximately one quarter of the patients. The declining response rates during the course of treatment suggest that transplantation should be implemented early during brentuximab vedotin treatment." @default.
• W2000545788 created "2016-06-24" @default.
• W2000545788 creator A5007982357 @default.
• W2000545788 creator A5011331320 @default.
• W2000545788 creator A5011548237 @default.
• W2000545788 creator A5012742859 @default.
• W2000545788 creator A5014836492 @default.
• W2000545788 creator A5019917883 @default.
• W2000545788 creator A5035484545 @default.
• W2000545788 creator A5036001242 @default.
• W2000545788 creator A5039160103 @default.
• W2000545788 creator A5041333987 @default.
• W2000545788 creator A5042105911 @default.
• W2000545788 creator A5047150136 @default.
• W2000545788 creator A5058897783 @default.
• W2000545788 creator A5060956242 @default.
• W2000545788 creator A5065201669 @default.
• W2000545788 creator A5083835943 @default.
• W2000545788 creator A5085246270 @default.
• W2000545788 creator A5091796118 @default.
• W2000545788 date "2014-09-18" @default.
• W2000545788 modified "2023-10-18" @default.
• W2000545788 title "Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey" @default.
• W2000545788 cites W1994835238 @default.
• W2000545788 cites W2035811581 @default.
• W2000545788 cites W2042932679 @default.
• W2000545788 cites W2112271707 @default.
• W2000545788 cites W2133201432 @default.
• W2000545788 cites W2141354859 @default.
• W2000545788 cites W2141846913 @default.
• W2000545788 cites W2149997323 @default.
• W2000545788 cites W2155256323 @default.
• W2000545788 doi "https://doi.org/10.1007/s00277-014-2215-9" @default.
• W2000545788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4317523" @default.
• W2000545788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25231929" @default.
• W2000545788 hasPublicationYear "2014" @default.
• W2000545788 type Work @default.
• W2000545788 sameAs 2000545788 @default.
• W2000545788 citedByCount "26" @default.
• W2000545788 countsByYear W20005457882015 @default.
• W2000545788 countsByYear W20005457882016 @default.
• W2000545788 countsByYear W20005457882017 @default.
• W2000545788 countsByYear W20005457882018 @default.
• W2000545788 countsByYear W20005457882019 @default.
• W2000545788 countsByYear W20005457882020 @default.
• W2000545788 countsByYear W20005457882021 @default.
• W2000545788 crossrefType "journal-article" @default.
• W2000545788 hasAuthorship W2000545788A5007982357 @default.
• W2000545788 hasAuthorship W2000545788A5011331320 @default.
• W2000545788 hasAuthorship W2000545788A5011548237 @default.
• W2000545788 hasAuthorship W2000545788A5012742859 @default.
• W2000545788 hasAuthorship W2000545788A5014836492 @default.
• W2000545788 hasAuthorship W2000545788A5019917883 @default.
• W2000545788 hasAuthorship W2000545788A5035484545 @default.
• W2000545788 hasAuthorship W2000545788A5036001242 @default.
• W2000545788 hasAuthorship W2000545788A5039160103 @default.
• W2000545788 hasAuthorship W2000545788A5041333987 @default.
• W2000545788 hasAuthorship W2000545788A5042105911 @default.
• W2000545788 hasAuthorship W2000545788A5047150136 @default.
• W2000545788 hasAuthorship W2000545788A5058897783 @default.
• W2000545788 hasAuthorship W2000545788A5060956242 @default.
• W2000545788 hasAuthorship W2000545788A5065201669 @default.
• W2000545788 hasAuthorship W2000545788A5083835943 @default.
• W2000545788 hasAuthorship W2000545788A5085246270 @default.
• W2000545788 hasAuthorship W2000545788A5091796118 @default.
• W2000545788 hasBestOaLocation W20005457881 @default.
• W2000545788 hasConcept C121332964 @default.
• W2000545788 hasConcept C126322002 @default.
• W2000545788 hasConcept C141071460 @default.
• W2000545788 hasConcept C142424586 @default.
• W2000545788 hasConcept C143998085 @default.
• W2000545788 hasConcept C2778191690 @default.
• W2000545788 hasConcept C2779338263 @default.
• W2000545788 hasConcept C2911091166 @default.
• W2000545788 hasConcept C2992779791 @default.
• W2000545788 hasConcept C71924100 @default.
• W2000545788 hasConcept C87355193 @default.
• W2000545788 hasConceptScore W2000545788C121332964 @default.
• W2000545788 hasConceptScore W2000545788C126322002 @default.
• W2000545788 hasConceptScore W2000545788C141071460 @default.
• W2000545788 hasConceptScore W2000545788C142424586 @default.
• W2000545788 hasConceptScore W2000545788C143998085 @default.
• W2000545788 hasConceptScore W2000545788C2778191690 @default.
• W2000545788 hasConceptScore W2000545788C2779338263 @default.
• W2000545788 hasConceptScore W2000545788C2911091166 @default.
• W2000545788 hasConceptScore W2000545788C2992779791 @default.
• W2000545788 hasConceptScore W2000545788C71924100 @default.
• W2000545788 hasConceptScore W2000545788C87355193 @default.
• W2000545788 hasIssue "3" @default.
• W2000545788 hasLocation W20005457881 @default.
• W2000545788 hasLocation W20005457882 @default.
• W2000545788 hasLocation W20005457883 @default.
• W2000545788 hasLocation W20005457884 @default.
• W2000545788 hasOpenAccess W2000545788 @default.
• W2000545788 hasPrimaryLocation W20005457881 @default.
• W2000545788 hasRelatedWork W1694038977 @default.
• W2000545788 hasRelatedWork W2117200606 @default.
• W2000545788 hasRelatedWork W2464239697 @default.

• next